Fiduciary duty and litigation

Lewandowski v. J&J and the employer mindset shift

Originally posted by

Hey Ann Lewandowski – you’re making change happen!

Shawn Gremminger in Axios today highlighted the employer mindset shift resulting from your lawsuit against J&J, which has highlighted a major challenge for employers: the lack of transparency in how pharmacy benefit managers (PBMs) handle drug costs.

More than half of employers are now reconsidering their PBM relationships in the next 1-3 years, demanding clearer terms like “rebate” and full revenue disclosure.

Employers are looking for real partnership to help manage rising healthcare costs and navigate complex compliance regulations.

Employers are pushing for the tools and transparency they need to make smarter, more cost-effective choices for their teams.

Regardless of how the lawsuit ends up, the American worker and their families are already better off for the increased focus.

Originally posted on LinkedIn, where the discussion and source links live in the comments.

About the author

Chris Vanderwolk is Director of Compliance and Innovation at OneDigital | Kistler Tiffany Benefits General Agency, where he helps brokers and employers navigate the regulatory complexity of employee benefits. An ERISA attorney with more than 19 years in the benefits industry, he specializes in translating what the law actually requires into language people can use.

All writing